首页> 外国专利> Compounds 4 - carboxiamino - 2 - substituted - 1,2,3,4 - Tetrahidroquinolina pharmacist; Pharmaceutical composition; kit; and use of the compounds as inhibitors of the Colesteril ester transfer protein (CETP) in the treatment of aterosclerosIs, Peripheral Vascular Disease, dyslipidemia, hypertriglyceridemia.

Compounds 4 - carboxiamino - 2 - substituted - 1,2,3,4 - Tetrahidroquinolina pharmacist; Pharmaceutical composition; kit; and use of the compounds as inhibitors of the Colesteril ester transfer protein (CETP) in the treatment of aterosclerosIs, Peripheral Vascular Disease, dyslipidemia, hypertriglyceridemia.

机译:化合物4-羧基氨基-2-取代的-1,2,3,4-四羟基喹啉药师;药物组合物;套件该化合物作为Collesteril酯转移蛋白(CETP)抑制剂的用途,用于治疗动脉粥样硬化,周围血管疾病,血脂异常,高甘油三酯血症。

摘要

Inhibitors of Protein Transfer Colesteril Ester Derivative, consisting of 4 - carboxiamino replaced - 2 - substituted - 1,2,3,4 tetrahydro - quinolinas formula I.Pharmaceutical compositions and Kits containing them and its use to raise levels of plasma Lipids, including cholesterol bound to high density lipoptrteinas,And to reduce certain levels of plasma Lipids, such as cholesterol and LDL and triglycerides and, accordingly,To treat diseases that are axacerban by low levels of HDL cholesterol and / or high levels of LDL cholesterol and triglycerides.And cardiovascular diseases such as atherosclerosis, dyslipidemia, hypertriglyceridemia in Mammals, including humans.
机译:蛋白质转移抑制剂Colesteril酯衍生物,由4-羧基氨基取代的-2-取代的-1,2,3,4四氢-喹啉I组成。药物组合物和含有它们的试剂盒及其在提高血浆脂质(包括胆固醇)水平中的用途绑定到高密度脂蛋白,并降低血浆脂质的某些水平,例如胆固醇和LDL和甘油三酸酯,因此,要治疗低水平的HDL胆固醇和/或高水平的LDL胆固醇和甘油三酸酯引起的阿克塞班疾病。以及包括人类在内的哺乳动物的心血管疾病,例如动脉粥样硬化,血脂异常,高甘油三酸酯血症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号